SEC Comment Letter for BiomX Inc. (PHGE) (CIK 0001739174) (HLSQ) — Dec 17, 2019
BiomX Inc. (PHGE) (CIK 0001739174)
Date: Dec. 17, 2019 · CIK: 0001739174 · Accession: 0000000000-19-016509
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-235507
Letter
December 17, 2019 Jonathan Solomon Chief Executive Officer BiomX Inc. 7 Pinhas Sapir Street, Floor 2 Ness Ziona, Israel 7414002 Re:BiomX Inc. Registration Statement on Form S-1 Filed December 13, 2019 File No. 333-235507 Dear Mr. Solomon: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Paul Fischer at 202-551-3415 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Anna Pinedo, Esq.
Show Raw Text
December 17, 2019
Jonathan Solomon
Chief Executive Officer
BiomX Inc.
7 Pinhas Sapir Street, Floor 2
Ness Ziona, Israel 7414002
Re:BiomX Inc.
Registration Statement on Form S-1
Filed December 13, 2019
File No. 333-235507
Dear Mr. Solomon:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Paul Fischer at 202-551-3415 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: Anna Pinedo, Esq.